[go: up one dir, main page]

ES518138A0 - Procedimiento para preparar piridazinas basicamente sustituidas. - Google Patents

Procedimiento para preparar piridazinas basicamente sustituidas.

Info

Publication number
ES518138A0
ES518138A0 ES518138A ES518138A ES518138A0 ES 518138 A0 ES518138 A0 ES 518138A0 ES 518138 A ES518138 A ES 518138A ES 518138 A ES518138 A ES 518138A ES 518138 A0 ES518138 A0 ES 518138A0
Authority
ES
Spain
Prior art keywords
alkoxy
basically
piridazines
procedure
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES518138A
Other languages
English (en)
Other versions
ES8400096A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Cassella Farbwerke Mainkur AG
Original Assignee
Cassella AG
Cassella Farbwerke Mainkur AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella AG, Cassella Farbwerke Mainkur AG filed Critical Cassella AG
Publication of ES518138A0 publication Critical patent/ES518138A0/es
Publication of ES8400096A1 publication Critical patent/ES8400096A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
ES518138A 1980-12-22 1982-12-13 Procedimiento para preparar piridazinas basicamente sustituidas. Expired ES8400096A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803048487 DE3048487A1 (de) 1980-12-22 1980-12-22 Basisch substituierte pyridazine, ihre herstellung und ihre verwendung

Publications (2)

Publication Number Publication Date
ES518138A0 true ES518138A0 (es) 1983-10-16
ES8400096A1 ES8400096A1 (es) 1983-10-16

Family

ID=6119960

Family Applications (3)

Application Number Title Priority Date Filing Date
ES508274A Granted ES508274A0 (es) 1980-12-22 1981-12-22 Procedimiento para preparar piridazinas basicamente sustituidas.
ES518139A Expired ES8308859A1 (es) 1980-12-22 1982-12-13 Procedimiento para preparar piridazinas basicamente sustituidas.
ES518138A Expired ES8400096A1 (es) 1980-12-22 1982-12-13 Procedimiento para preparar piridazinas basicamente sustituidas.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES508274A Granted ES508274A0 (es) 1980-12-22 1981-12-22 Procedimiento para preparar piridazinas basicamente sustituidas.
ES518139A Expired ES8308859A1 (es) 1980-12-22 1982-12-13 Procedimiento para preparar piridazinas basicamente sustituidas.

Country Status (26)

Country Link
US (1) US4532239A (es)
EP (1) EP0054946B1 (es)
JP (1) JPS57128677A (es)
KR (1) KR880002233B1 (es)
AT (1) ATE8991T1 (es)
AU (1) AU544386B2 (es)
CA (1) CA1173033A (es)
CS (1) CS236665B2 (es)
DD (1) DD202013A5 (es)
DE (2) DE3048487A1 (es)
DK (1) DK149810C (es)
ES (3) ES508274A0 (es)
FI (1) FI73418C (es)
GR (1) GR81382B (es)
HK (1) HK51485A (es)
IE (1) IE51985B1 (es)
IL (1) IL64605A (es)
NO (1) NO814182L (es)
NZ (1) NZ198919A (es)
PH (1) PH17529A (es)
PL (3) PL137150B1 (es)
PT (1) PT74185B (es)
RO (3) RO88190B (es)
SG (1) SG7585G (es)
SU (2) SU1170970A3 (es)
ZA (1) ZA818806B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
EP0201765B1 (en) * 1985-04-27 1991-09-18 Nissan Chemical Industries Ltd. 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
JPS61282194A (ja) * 1985-06-06 1986-12-12 Yukio Nakamura ジエツト推進式舟艇の推進軸とその製造法
JPH0629254B2 (ja) * 1986-09-08 1994-04-20 帝国臓器製薬株式会社 ピリダジノン誘導体
DE3902316A1 (de) * 1989-01-26 1990-08-02 Lentia Gmbh Neue piperazinylalkyl-3(2h)-pyridazinone, verfahren zu ihrer herstellung und ihre verwendung als blutdrucksenkende mittel
US5221674A (en) * 1989-06-19 1993-06-22 Teikoku Hormone Mfg. Co., Ltd. Pyridazinone derivatives
NZ234087A (en) * 1989-06-19 1991-08-27 Teikoku Hormone Mfg Co Ltd 2-(3-aryloxy(2-hydroxy-propylamino))-2-methylpropyl- aminophenyl pyridazine derivatives
HU214320B (hu) * 1991-12-20 1998-03-02 EGIS Gyógyszergyár Rt. Eljárás új 3(2H)-piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására
AU752967B2 (en) * 1998-06-05 2002-10-03 Egis Gyogyszergyar Rt. Process for the preparation of a 3(2H)-pyridazinone- 4-substituted amino- 5-chloro- derivative
EP2137179B1 (en) * 2007-03-15 2015-09-02 Merck Sharp & Dohme Corp. Pyridazinone derivatives useful as glucan synthase inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA957364A (en) * 1968-11-18 1974-11-05 Pfizer Corporation Preparation of polar-substituted phenyl propanolamines
GB1421999A (en) * 1973-02-08 1976-01-21 Smith Kline French Lab Heterocyclic containing sulphoxides
US4115575A (en) * 1973-02-20 1978-09-19 Ciba-Geigy Corporation 2-(3-Amino-2-hydroxy-propoxy)-pyrazines
GB1488330A (en) * 1973-12-19 1977-10-12 Smith Kline French Lab Dihydropyridazinones
US4088764A (en) * 1973-12-27 1978-05-09 Cassella Farbwerke Mainkur Aktiengesellschaft Pharmaceutically active derivatives of 1-phenoxy-3-amino-propan-2-ol
CH594626A5 (es) * 1974-05-14 1978-01-13 Ciba Geigy Ag
LU77339A1 (es) * 1977-05-16 1979-01-19
DD146749A3 (de) * 1977-12-01 1981-03-04 Dieter Lehmann Verfahren zur herstellung von phenoxyalkanolamin-derivaten
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
PL137106B1 (en) 1986-04-30
CA1173033A (en) 1984-08-21
GR81382B (es) 1984-12-11
AU544386B2 (en) 1985-05-23
RO88190A (ro) 1985-12-30
RO84277A (ro) 1984-05-23
FI813941L (fi) 1982-06-23
PL234312A1 (en) 1983-02-14
PL136127B1 (en) 1986-01-31
FI73418C (fi) 1987-10-09
IE813014L (en) 1982-06-22
DE3165595D1 (en) 1984-09-20
SU1170970A3 (ru) 1985-07-30
PL238537A1 (en) 1983-06-20
NZ198919A (en) 1985-05-31
CS236665B2 (en) 1985-05-15
HK51485A (en) 1985-07-12
SU1151204A3 (ru) 1985-04-15
DK149810B (da) 1986-10-06
DK542881A (da) 1982-06-23
PL137150B1 (en) 1986-05-31
RO84277B (ro) 1984-07-30
NO814182L (no) 1982-06-23
ES8304941A1 (es) 1983-03-16
IL64605A (en) 1985-11-29
ES518139A0 (es) 1983-10-01
DD202013A5 (de) 1983-08-24
RO88201A (ro) 1985-12-30
IE51985B1 (en) 1987-05-13
PL238538A1 (en) 1983-04-25
RO88190B (ro) 1985-12-31
SG7585G (en) 1985-08-08
KR830007577A (ko) 1983-11-04
ES8308859A1 (es) 1983-10-01
RO88201B (ro) 1985-12-31
DE3048487A1 (de) 1982-07-29
US4532239A (en) 1985-07-30
DK149810C (da) 1987-03-23
JPS57128677A (en) 1982-08-10
PT74185B (de) 1987-03-24
ATE8991T1 (de) 1984-09-15
IL64605A0 (en) 1982-03-31
PT74185A (de) 1982-01-01
ZA818806B (en) 1982-11-24
AU7870481A (en) 1982-07-01
EP0054946A1 (de) 1982-06-30
EP0054946B1 (de) 1984-08-15
KR880002233B1 (ko) 1988-10-20
PH17529A (en) 1984-09-13
ES8400096A1 (es) 1983-10-16
ES508274A0 (es) 1983-03-16
FI73418B (fi) 1987-06-30

Similar Documents

Publication Publication Date Title
ES518138A0 (es) Procedimiento para preparar piridazinas basicamente sustituidas.
ES519615A0 (es) Un procedimiento para la preparacion de nuevas 1,2,3,4-tetrahidro-2-naftilaminas.
ES496074A0 (es) Un procedimiento para la preparacion de derivados de morfo- lina
KR870700613A (ko) 신규 벤조티아진 유도체
AU560141B2 (en) Piperazine derivatives of theophylline
ZA825528B (en) Piperazine derivatives of theobromine
ES8705405A1 (es) Procedimiento de preparar nuevos derivados morfolinicos
SE7910333L (sv) 3-hydroxu-1,4-bensodiazepin-2-oner